Exploring Human Microbiota's Biosynthetic Potential for Antimicrobial Discovery

The escalating threat of multidrug-resistant superbugs demands urgent development of effective antimicrobials. This study focuses on the millions of tiny microbes in our bodies, collectively called the human microbiome, which holds immense potential for producing health-affecting substances. Among these substances, there are certain types of antimicrobial peptides that have caught researchers' attention because of their unique structure and ability to kill harmful microbes. These peptides are not only safe for us, but they also have a lower chance of causing bugs to become resistant to drugs.This project is set out to find new germ-fighting peptides from the largely unexplored world of our body's own microbes. The study explores their potential using sophisticated techniques to study the genetic capabilities of these microbes and obtain these peptides synthetically in a lab. The next steps involve testing how well these germ-fighting peptides can prevent infection and understanding how they function. In brief, using a mix of techniques, including data mining, synthetic science, and biological activity testing, the team strives to unleash the potential of our body's microbes to produce these antimicrobial peptides.